Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William H Eaglstein

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Archives of Dermatology|October 20, 2010
Evidence-based medicine, the research-practice gap, and biases in medical and surgical decision making in dermatologyWilliam H Eaglstein
The Journal of Investigative Dermatology|November 10, 2015
The FDA: Doctors, Investigators, and Translational ResearchWilliam H Eaglstein
JAMA Dermatology|November 26, 2015
Innovative New Drugs for Serious Nonlethal Diseases: The Cost to Develop and the Cost to BuyWilliam H Eaglstein
Journal of the American Academy of Dermatology|February 8, 2018
Real-world evidence-What is it and does it matter for approval of drugs?William H Eaglstein
Archives of Dermatology|September 17, 2008
Victor H. Witten, MD: creator of the National Library of Medicine "Audio History of Dermatology"William H Eaglstein
The Journal of Investigative Dermatology|September 16, 2023
Irreproducibility of Preclinical Studies: Implications for Dermatologists and Dermatologic InvestigatorsWilliam H Eaglstein
JAMA Dermatology|October 25, 2013
Me-too drugs and me-too peopleWilliam H Eaglstein
Archives of Dermatology|May 18, 2011
New drugs and new molecular entities in dermatologyWilliam H Eaglstein, Gavin Corcoran
Dermatologic Clinics|April 20, 2005
Cyanoacrylates for skin closureWilliam H Eaglstein, Tory Sullivan
Skinmed|May 10, 2011
Clinical trials in perspectiveWilliam H Eaglstein, Lawrence Charles Parish
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Archives of Dermatology|October 20, 2010
Evidence-based medicine, the research-practice gap, and biases in medical and surgical decision making in dermatologyWilliam H Eaglstein
The Journal of Investigative Dermatology|November 10, 2015
The FDA: Doctors, Investigators, and Translational ResearchWilliam H Eaglstein
JAMA Dermatology|November 26, 2015
Innovative New Drugs for Serious Nonlethal Diseases: The Cost to Develop and the Cost to BuyWilliam H Eaglstein
Journal of the American Academy of Dermatology|February 8, 2018
Real-world evidence-What is it and does it matter for approval of drugs?William H Eaglstein
Archives of Dermatology|September 17, 2008
Victor H. Witten, MD: creator of the National Library of Medicine "Audio History of Dermatology"William H Eaglstein
The Journal of Investigative Dermatology|September 16, 2023
Irreproducibility of Preclinical Studies: Implications for Dermatologists and Dermatologic InvestigatorsWilliam H Eaglstein
JAMA Dermatology|October 25, 2013
Me-too drugs and me-too peopleWilliam H Eaglstein
Archives of Dermatology|May 18, 2011
New drugs and new molecular entities in dermatologyWilliam H Eaglstein, Gavin Corcoran
Dermatologic Clinics|April 20, 2005
Cyanoacrylates for skin closureWilliam H Eaglstein, Tory Sullivan
Skinmed|May 10, 2011
Clinical trials in perspectiveWilliam H Eaglstein, Lawrence Charles Parish
Pageof 3